MedPath

comparing the effectiveness of different doses of norepinephrine immediately after giving spinal anaesthesia to prevent fall in blood pressure during caesarean section.

Completed
Conditions
Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium,
Registration Number
CTRI/2020/04/024801
Lead Sponsor
Kasturba medical college
Brief Summary

Comparison of efficacy of two different bolus doses of norepinephrine as prophylactic to prevent postspinal hypotension during elective caesarean section.

This study aims to compare the efficacy of two different bolus dosages of norepinephrine in effectively reducing the incidence of post spinal hypotension during elective caesarean section thereby improves maternal and fetal outcomes.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
84
Inclusion Criteria
  • 1.Pregnant females undergoing elective caesarean section under spinal anaesthesia.
  • 2.Full term pregnancy.
  • 3.Singleton pregnancy.
  • 4.BP range 90-140 mmHg 5.ASA physical status II 6.Age 18 years and older.
  • 7.Weight between 50 and 100 kg.
  • 8.Height between 150 and 170 cm.
Exclusion Criteria
  • Patient refusal.
  • Hypertension, cardiovascular or cerebrovascular disease.
  • Fetal abnormalities.
  • Diabetes (excluding gestational diabetes).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Success of prophylactic iv bolus of norepinephrine to maintain SBP at or above 80% of baselinefrom induction to delivery of foetus
Secondary Outcome Measures
NameTimeMethod
1.Hypertension2.Bradycardia

Trial Locations

Locations (1)

Kasturba Medical College,Wenlock Government Hospital,Mangalore

🇮🇳

Kannada, KARNATAKA, India

Kasturba Medical College,Wenlock Government Hospital,Mangalore
🇮🇳Kannada, KARNATAKA, India
Dr Garapati Pranathi
Principal investigator
9666740160
pranathi.garapati@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.